COMMUNIQUÉS West-GlobeNewswire

Sienna Senior Living Inc. Announces Results From Annual and Special Meeting
29/05/2024
MARKHAM, Ontario, May 29, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) is pleased to announce that it has received shareholder approval in respect of all resolutions to [...]
Certara to Participate in the Jefferies Global Healthcare Conference
29/05/2024
RADNOR, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global Healthcare Conference. [...]
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
29/05/2024
Nes-Ziona, Israel, May 29, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the closing of its previously [...]
Participation de Merus à un échange informel à l’occasion de la conférence Jefferies Global Healthcare
29/05/2024
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 29 mai 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une société d’oncologie au stade clinique développant des anticorps pleine longueur multispécifiques et [...]
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
29/05/2024
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 29, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients [...]
GENFIT présentera ses dernières avancées dans l'ACLF à l'EASL Congress™ 2024
29/05/2024
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), 29 mai 2024 - GENFIT (Nasdaq et Euronext : GNFT) , une société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des [...]
Enliven Therapeutics to Present at Two Upcoming Investor Conferences
29/05/2024
BOULDER, Colo., May 29, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next-generation small [...]
Immuneering to Present at the Jefferies Global Healthcare Conference
29/05/2024
CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of [...]
Cardiff Oncology to Present at the Jefferies Healthcare Conference
29/05/2024
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced [...]
Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
29/05/2024
SEATTLE, May 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine
29/05/2024
QIAseq Multimodal DNA/RNA Lib Kit enables streamlined DNA and RNA library preparation for next-generation sequencing from a single sample // New kit advances precision medicine by facilitating multiomic studies and [...]
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
29/05/2024
TAMPA, FL, May 29, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. ( Nasdaq: MEDS ) (the “Company”), announced that, on May 23, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications [...]
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
29/05/2024
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]
OneMedNet Inks Agreement with a Global Top-10 Medical Technology Company
29/05/2024
OneMedNet’s new iRWD™ platform customer impacts more than 150 million patients each year MINNEAPOLIS, May 29, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading [...]
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference
29/05/2024
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of [...]
Additional Data Showing Acoramidis Increases Serum Transthyretin Which is Associated with Improved Cardiovascular Outcomes Presented at ISA from BridgeBio Pharma’s Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
29/05/2024
- Acoramidis treatment resulted in increased serum transthyretin (TTR) levels by Day 28 that were sustained and were correlated with a reduced risk of all-cause mortality (ACM), cardiovascular mortality (CVM), and [...]
scPharmaceuticals to Present at the Jefferies Global Healthcare Conference
29/05/2024
BURLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of [...]
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024
29/05/2024
Following a recently completed Type B meeting with the FDA, Immunovant is on track to initiate 4 to 5 potentially registrational studies for its lead asset IMVT-1402 in endocrinology, neurology, and other therapeutic [...]
Cytokinetics to Participate in June Investor Conferences
29/05/2024
SOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor conferences in June: [...]

Pages